Zinc Supplementation Partially Reconstitutes Impaired Interferon-γ Production in the Elderly.

Elderly hospitalized patients exhibited lower zinc status compared to young healthy controls.

• Serum zinc levels were measured and compared between elderly hospitalized patients and young healthy controls.
• Dietary zinc intake was assessed as part of the zinc status evaluation.
• Proton pump inhibitor (PPI) use among the elderly correlated with zinc deficiency.
• The study assessed zinc status as part of a broader investigation into age-related immune decline.

Elderly participants showed lower PHA-stimulated IFN-γ production compared to young healthy controls.

• IFN-γ production was assessed using phytohemagglutinin (PHA) stimulation.
• The reduction in IFN-γ levels was observed alongside lower zinc status in the elderly group.
• This finding is consistent with the known immunosenescence associated with aging.

PPI use among elderly participants was correlated with zinc deficiency.

• Proton pump inhibitor use was recorded as part of the patient assessment.
• PPI use was identified as a factor associated with zinc deficiency in the elderly cohort.
• This correlation suggests that PPI use may contribute to impaired zinc absorption in elderly patients.

Zinc aspartate supplementation for approximately 7 days increased serum zinc levels in zinc-deficient elderly participants.

• Zinc-deficient elderly participants received zinc aspartate supplementation.
• The supplementation duration was approximately 7 days.
• Serum zinc levels increased following supplementation.
• The intervention was conducted in a hospitalized elderly patient population.

Zinc supplementation increased IFN-γ production in zinc-deficient elderly participants.

• PHA-stimulated IFN-γ production increased following approximately 7 days of zinc aspartate supplementation.
• The increase in IFN-γ production was observed alongside the increase in serum zinc levels.
• The results indicate a partial reconstitution of impaired IFN-γ production in the elderly following zinc supplementation.

Zinc supplementation showed a trend toward increased ZIP8 expression, which reached statistical significance in participants taking PPIs.

• ZIP8 protein expression was measured before and after zinc aspartate supplementation.
• An overall trend toward increased ZIP8 expression was observed following supplementation, though it did not reach statistical significance in the full cohort.
• In elderly participants who were also taking PPIs, the increase in ZIP8 expression reached statistical significance.
• ZIP8 is known to facilitate IFN-γ production by increasing intracellular zinc levels.

No clear correlation was found between ZIP8 expression and zinc status in the study participants.

• ZIP8 protein expression was assessed alongside serum zinc levels and dietary zinc intake.
• The absence of a clear correlation between ZIP8 expression and zinc status suggests the relationship is complex.
• The authors noted that how zinc status in humans affects ZIP8 expression remains unclear.
• The observed response to supplementation was described as warranting further investigation.

ZIP8 facilitates IFN-γ production by increasing intracellular zinc levels, with new molecular mechanisms continuing to be identified.

• ZIP8 is a zinc transporter involved in modulating intracellular zinc levels.
• The mechanism by which ZIP8 facilitates IFN-γ production involves increasing intracellular zinc.
• The precise mechanisms linking zinc status to IFN-γ production, particularly regarding ZIP8 expression levels, require further elucidation according to the authors.